FGF23 and chronic kidney disease: Increased blood levels of fibroblast growth factor (FGF)-23 are found early during the development of CKD-MBD and are considered a compensatory mechanism to avoid hyperphosphatemia and resultant hyperparathyroidism and turnover abnormalities [3, 4, 5].